Vision-Sciences digital endoscopes:
This article was originally published in Clinica
Executive Summary
Vision-Sciences has received 510(k) clearance from the US FDA for two of its advanced digital endoscopes, which the firm claims are "poised to replace prevalent old fibre-optic technology". The video-based endoscopes - one for ear, nose and throat (ENT) assessment, and the other for transnasal oesophagoscopy (TNO) - come with a built-in light source, eliminating the need for a separate camera head, light cable and optical coupler. The Orangeburg, New York firm also claims that the products contain the world's smallest diameter insertion tube that incorporates a tiny high-resolution camera. The endoscopes can be used in conjunction with Vision-Sciences' Endosheath, which covers the entire device during examination in order to prevent the transfer of infection, and reduces the amount of high-level disinfection needed between procedures.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.